Grantham, Mayo, Van Otterloo & Co (GMO)’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $751M | Buy |
1,851,305
+395,225
| +27% | +$160M | 2.26% | 16 |
|
|
2025
Q1 | $725M | Buy |
1,456,080
+362,214
| +33% | +$180M | 2.28% | 13 |
|
|
2024
Q4 | $569M | Buy |
1,093,866
+639,467
| +141% | +$333M | 1.85% | 20 |
|
|
2024
Q3 | $281M | Buy |
454,399
+28,760
| +7% | +$17.8M | 0.88% | 29 |
|
|
2024
Q2 | $235M | Buy |
+425,639
| New | +$235M | 0.8% | 30 |
|
|
2022
Q4 | – | Sell |
-2,700
| Closed | -$1.37M | – | 777 |
|
|
2022
Q3 | $1.37M | Buy |
+2,700
| New | +$1.37M | 0.01% | 466 |
|
|
2018
Q4 | – | Sell |
-3,300
| Closed | -$805K | – | 577 |
|
|
2018
Q3 | $805K | Sell |
3,300
-300
| -8% | -$73.2K | 0.01% | 386 |
|
|
2018
Q2 | $746K | Hold |
3,600
| – | – | 0.01% | 397 |
|
|
2018
Q1 | $743K | Sell |
3,600
-200
| -5% | -$41.3K | ﹤0.01% | 396 |
|
|
2017
Q4 | $722K | Buy |
3,800
+2,100
| +124% | +$399K | ﹤0.01% | 377 |
|
|
2017
Q3 | $322K | Buy |
+1,700
| New | +$322K | ﹤0.01% | 443 |
|
|
2017
Q2 | – | Sell |
-1,800
| Closed | -$276K | – | 603 |
|
|
2017
Q1 | $276K | Buy |
+1,800
| New | +$276K | ﹤0.01% | 424 |
|
|
2014
Q2 | – | Sell |
-18,200
| Closed | -$2.19M | – | 554 |
|
|
2014
Q1 | $2.19M | Sell |
18,200
-25,365
| -58% | -$3.05M | 0.01% | 405 |
|
|
2013
Q4 | $4.85M | Buy |
43,565
+37,890
| +668% | +$4.22M | 0.01% | 316 |
|
|
2013
Q3 | $523K | Sell |
5,675
-6,300
| -53% | -$581K | ﹤0.01% | 543 |
|
|
2013
Q2 | $1.01M | Buy |
+11,975
| New | +$1.01M | ﹤0.01% | 461 |
|